Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

被引：0
|
作者：
Eric Southam
Jackie Cilia
Jane E. Gartlon
Marie L. Woolley
Laurent P. Lacroix
Carol A. Jennings
Jane E. Cluderay
Charlie Reavill
Claire Rourke
David M. Wilson
Lee A. Dawson
Andrew D. Medhurst
Declan N. C. Jones
机构：
[1] GlaxoSmithKline,
来源：
Psychopharmacology | 2009年 / 201卷
关键词：
Antipsychotic; Autoradiography; c-; Cognition; Dopamine; Haloperidol; Histamine; Microdialysis; Prepulse inhibition; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 494
页数：11
相关论文
共 50 条
  • [41] Minimization of potential hERG liability in histamine H3 receptor antagonists
    L. A. Black
    H. Liu
    G. J. Diaz
    G. B. Fox
    K. E. Browman
    J. Wetter
    K. C. Marsh
    T. R. Miller
    T. A. Esbenshade
    J. Brioni
    M. D. Cowart
    Inflammation Research, 2008, 57 : 45 - 46
  • [42] Histamine H3 receptor antagonists:: Preclinical promise for treating obesity and cognitive disorders
    Esbenshade, TA
    Fox, GB
    Cowart, MD
    MOLECULAR INTERVENTIONS, 2006, 6 (02) : 77 - 88
  • [43] THE NOVEL HISTAMINE H3 RECEPTOR ANTAGONIST ST-1283 ATTENUATES ETHANOL CONSUMPTION AND PREFERENCE IN MICE
    Sadek, B.
    Bahi, A.
    Walter, M.
    Schwed, J. S.
    Kottke, T.
    Stark, H.
    INFLAMMATION RESEARCH, 2012, 61 : S63 - S63
  • [44] Minimization of potential hERG liability in histamine H3 receptor antagonists
    Black, L. A.
    Liu, H.
    Diaz, G. J.
    Fox, G. B.
    Browman, K. E.
    Wetter, J.
    Marsh, K. C.
    Miller, T. R.
    Esbenshade, T. A.
    Brioni, J.
    Cowart, M. D.
    INFLAMMATION RESEARCH, 2008, 57 (Suppl 1) : S45 - S46
  • [45] AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects
    Jucaite, Aurelija
    Takano, Akihiro
    Bostrom, Emma
    Jostell, Karl-Gustav
    Stenkrona, Per
    Halldin, Christer
    Segerdahl, Marta
    Nyberg, Svante
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (06): : 1231 - 1239
  • [46] Novel amides as potent and selective histamine H3 receptor antagonists
    Nirogi, Ramakrishna
    Shinde, Anil
    Kambhampati, Ramasastri
    Deshpande, Amol
    Dwarampudi, Adireddy
    Gangadasari, Narsimhareddy
    Cheppala, Atreya
    Rambabu, Namala
    Kandikere, Vishwottam
    Jayarajan, Pradeep
    Muddana, Nageswararao
    Ahmad, Ishtiyaque
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [47] Physicochemical properties approach to the identification of a histamine H3 receptor antagonist for the treatment of ADHD
    Wager, Travis T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [48] PIPERAZINE DERIVATIVES AS A NOVEL, ACTIVE HISTAMINE H3 RECEPTOR LIGANDS
    Szczepanska, K.
    Karcz, T.
    Mogilski, S.
    Kuder, K. J.
    Hagenow, S.
    Kotanska, M.
    Stark, H.
    Kiec-Kononowicz, K.
    INFLAMMATION RESEARCH, 2018, 67 : S30 - S30
  • [49] Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B
    Hagenow, S.
    Stasiak, A.
    Ramsay, R. R.
    Stark, H.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Novel H3 receptor antagonists.: Sulfonamide homologs of histamine
    Wolin, R
    Connolly, M
    Afonso, A
    Hey, JA
    She, H
    Rivelli, MA
    Willams, SM
    West, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2157 - 2162
12345